Style | Citing Format |
---|---|
MLA | Riaziesfahani M, et al.. "Intravitreal Bevacizumab Alone or Combined With 1 Mg Triamcinolone in Diabetic Macular Edema: A Randomized Clinical Trial." International Ophthalmology, vol. 38, no. 2, 2018, pp. 585-598. |
APA | Riaziesfahani M, Riaziesfahani H, Ahmadraji A, Karkhaneh R, Mahmoudi A, Roohipoor R, Ghasemi F, Yaseri M (2018). Intravitreal Bevacizumab Alone or Combined With 1 Mg Triamcinolone in Diabetic Macular Edema: A Randomized Clinical Trial. International Ophthalmology, 38(2), 585-598. |
Chicago | Riaziesfahani M, Riaziesfahani H, Ahmadraji A, Karkhaneh R, Mahmoudi A, Roohipoor R, Ghasemi F, Yaseri M. "Intravitreal Bevacizumab Alone or Combined With 1 Mg Triamcinolone in Diabetic Macular Edema: A Randomized Clinical Trial." International Ophthalmology 38, no. 2 (2018): 585-598. |
Harvard | Riaziesfahani M et al. (2018) 'Intravitreal Bevacizumab Alone or Combined With 1 Mg Triamcinolone in Diabetic Macular Edema: A Randomized Clinical Trial', International Ophthalmology, 38(2), pp. 585-598. |
Vancouver | Riaziesfahani M, Riaziesfahani H, Ahmadraji A, Karkhaneh R, Mahmoudi A, Roohipoor R, et al.. Intravitreal Bevacizumab Alone or Combined With 1 Mg Triamcinolone in Diabetic Macular Edema: A Randomized Clinical Trial. International Ophthalmology. 2018;38(2):585-598. |
BibTex | @article{ author = {Riaziesfahani M and Riaziesfahani H and Ahmadraji A and Karkhaneh R and Mahmoudi A and Roohipoor R and Ghasemi F and Yaseri M}, title = {Intravitreal Bevacizumab Alone or Combined With 1 Mg Triamcinolone in Diabetic Macular Edema: A Randomized Clinical Trial}, journal = {International Ophthalmology}, volume = {38}, number = {2}, pages = {585-598}, year = {2018} } |
RIS | TY - JOUR AU - Riaziesfahani M AU - Riaziesfahani H AU - Ahmadraji A AU - Karkhaneh R AU - Mahmoudi A AU - Roohipoor R AU - Ghasemi F AU - Yaseri M TI - Intravitreal Bevacizumab Alone or Combined With 1 Mg Triamcinolone in Diabetic Macular Edema: A Randomized Clinical Trial JO - International Ophthalmology VL - 38 IS - 2 SP - 585 EP - 598 PY - 2018 ER - |